Shares of OpenText (TSX:OTC) are getting hit today after the company announced a comprehensive restructuring that will reduce the size of its workforce by five per cent.
CEO Mark Barrenechea, whom the company also announced is returning to work after leaving for leukemia treatment, said the move would not impact the Waterloo-based company’s topline.
“Effective immediately, we are announcing a simplification of our business structure around enterprise, information exchange and analytics, as well as a new global technical services organization,” he said. “This structure will allow us to scale as we continue to acquire complementary businesses over time, and will provide additional focus on winning the customer and capturing the lifetime value of that relationship. As a result of the restructuring, we expect to save approximately $50-million in annualized operating expense, accretive to fiscal year 2016 earnings and with little to no impact on revenues.”
OpenText says it will focus on its cloud business strategy to deliver growth. Management says it want to be a leader in the Enterprise Information Management (EIM) space. The company notes that its cloud business now accounts for nearly a third of its overall topline, a number that was zero just three years ago.
OpenText says it will face a pretax restructuring charge of about $25-million, mostly owing to employee severance arrangements and facility expenses. The company yesterday shuffled the deck on its management, parting ways with Jon Hunter, executive vice-president, worldwide field operations, and appointing James McGourlay, senior vice-president, global technical services, and Simon Harrison, senior vice-president, enterprise sales, amongst other appointments.
At press time, shares of OpenText on the TSX were down 13.1% to $51.97.
Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]
It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]
Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]
Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]
It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]
Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]
View Comments
no no... please don't use "CEO's health issues" to create sympathy. It's looks too bad for company's reputation. Simple - Stop buying more companies if you don't know what you are doing with employees or how to use Govt (people's) money.